Press Release: Cyberonics : LivaNova Recognizes International Epilepsy Day
LONDON--(BUSINESS WIRE)--$LIVN--Approximately two million people in Europe with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options.
Read full article »
Cyberonics designs, develops and markets patient-focused medical devices for people affected by epilepsy, depression and other chronic disorders.
Read more